Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

Optimizing Clinical Trial Efficiency: The Power of Simplicity for First-in-Human Studies

How industry can increase the speed of these trials while continuing to meet patient needs.

The Takeaway From Study of Midlife MS Patients: Don't Stop Disease-Modifying Therapy

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop disease-modifying therapy have higher hospitalization rates and more visits to the emergency room.

From AI to Hardware Costs: Enterprise Tech Leaders Prepare for Trump 2.0

The president-elect’s focus on tariffs and reducing regulation could affect hardware costs and AI deployments, and set off an M&A frenzy, CIOs say.

No-Cost Heart & Kidney Health Screenings Coming to Philadelphia to Detect Dangerous Type of Cholesterol You’ve Probably Never Tested For

Care Access is bringing its Heart & Kidney Health Screening initiative to Philadelphia, Pa. This health screening aims to raise awareness and provide testing for certain health risk factors, including a dangerous type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five people and significantly increases the risk of heart disease and stroke.
Leslie Athmer on LinkedIn

Women in leadership roles is a hot topic this week for obvious reasons. This timely article from SonarMD's CEO Beth Houck highlights a few female led companies in our digital health specialty care space. Let's continue to embrace change, drive down risk and be more profitable along the way. 👏

"Interestingly, SonarMD and Wildflower Health are two value-added, specialty care companies that are led by women and there are many others including Iron Health, TailorCare, Midi Health, and Maven Clinic, to name a few. What is driving this trend when across healthcare women remain underrepresented in leadership roles? Research suggests that it might have to do with their ability to embrace change while dialing down risk, plus women-led companies are often more profitable." 💡

#femaleleadership #valuebasedcare #vbc #specialtycare #digitalhealth

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs